Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P42356: Variant p.Asp1664Asn

Phosphatidylinositol 4-kinase alpha
Gene: PI4KA
Feedback?
Variant information Variant position: help 1664 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Asparagine (N) at position 1664 (D1664N, p.Asp1664Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In NEDSPLB. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1664 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2102 The length of the canonical sequence.
Location on the sequence: help SFPPDAILFYIPQIVQALRY D KMGYVREYILWAASKSQLLA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SFPPDAILFYIPQIVQALRYDKMGYVREYILWAASKSQLLA

Mouse                         SFPPDAILFYIPQIVQALRYDKMGYVREYILWAAAKSQLLA

Rat                           SFPPDAILFYIPQIVQALRYDKMGYVREYILWAAAKSQLLA

Bovine                        SFPPDAILFYIPQIVQALRYDKMGYVREYILWAASQSQLLA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2102 Phosphatidylinositol 4-kinase alpha
Domain 1530 – 1718 PIK helical



Literature citations
Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy.
Verdura E.; Rodriguez-Palmero A.; Velez-Santamaria V.; Planas-Serra L.; de la Calle I.; Raspall-Chaure M.; Roubertie A.; Benkirane M.; Saettini F.; Pavinato L.; Mandrile G.; O'Leary M.; O'Heir E.; Barredo E.; Chacon A.; Michaud V.; Goizet C.; Ruiz M.; Schlueter A.; Rouvet I.; Sala-Coromina J.; Fossati C.; Iascone M.; Canonico F.; Marce-Grau A.; de Souza P.; Adams D.R.; Casasnovas C.; Rehm H.L.; Mefford H.C.; Gonzalez Gutierrez-Solana L.; Brusco A.; Koenig M.; Macaya A.; Pujol A.;
Brain 144:2659-2669(2021)
Cited for: VARIANTS NEDSPLB TRP-119; ARG-472; 618-ARG--TYR-2102 DEL; LYS-1152; THR-1198; ARG-1295; ASN-1664; ASN-1854; ARG-1925; SER-1987 AND THR-2041; VARIANTS SPG84 MET-1556; ILE-1720 AND GLU-1820 DEL; INVOLVEMENT IN NEDSPLB; INVOLVEMENT IN SPG84;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.